Latest Tax Refunds News

Page 6 of 11
Imugene Limited reports strong clinical progress with its off-the-shelf CAR T therapy azer-cel achieving a 75% overall response rate in Phase 1b trials, alongside new patents and leadership appointments. The company also secured $22.5 million in fresh funding to advance pivotal trials.
Ada Torres
Ada Torres
31 July 2025
Australian Vanadium Limited (AVL) reports strong progress on its integrated vanadium project, moving closer to final feasibility and advancing its utility-scale battery storage system, Project Lumina.
Maxwell Dee
Maxwell Dee
31 July 2025
Zimi Limited has completed production of its Smoke Connect safety range, progressed Matter Connect certification, and moved Senoa manufacturing to a new facility, while engaging investors for a capital raise.
Sophie Babbage
Sophie Babbage
30 July 2025
Environmental Clean Technologies Limited has secured crucial regulatory approvals for its Bacchus Marsh fertiliser facility and completed a $275K capital raise, while deferring field trials to better align with cropping cycles. The company is also undergoing significant restructuring to improve capital efficiency and focus on strategic growth.
Victor Sage
Victor Sage
30 July 2025
ACDC Metals has reported strong scoping study results for its Goschen Central heavy mineral sands and rare earth project, highlighting a promising 14-year mine life and a strategic retention licence application to support ongoing development.
Maxwell Dee
Maxwell Dee
30 July 2025
IGO Limited reported a robust operational quarter with improved safety and solid production at Greenbushes and Nova, offset by challenges at its Kwinana lithium refinery and an expected asset impairment.
Maxwell Dee
Maxwell Dee
30 July 2025
IGO Limited reported robust operational performance in Q4 FY25 with improved safety and higher production at Greenbushes and Nova, while facing significant impairment at its Kwinana lithium refinery.
Maxwell Dee
Maxwell Dee
30 July 2025
Patrys Limited has completed a modest capital raise and restructured its leadership as it advances its deoxymab antibody program, with a larger entitlement offer announced to fund clinical development and business growth.
Ada Torres
Ada Torres
29 July 2025
Anatara Lifesciences reports Phase II GaRP-IBS trial results showing no safety concerns but missing the primary efficacy endpoint, while securing key patents and receiving a significant R&D tax refund.
Ada Torres
Ada Torres
29 July 2025
Anatara Lifesciences has received nearly $1 million from the Australian Government’s R&D tax incentive, providing a vital capital injection to advance its Anti-Obesity pre-clinical studies.
Ada Torres
Ada Torres
28 July 2025
Stanmore Resources has reported a robust recovery in its June quarter operations with increased coal production, zero serious safety incidents, and positive cash flow, despite challenging weather conditions. The company maintains its full-year production guidance, signaling resilience amid market uncertainties.
Maxwell Dee
Maxwell Dee
28 July 2025
Antares Metals has reported promising exploration progress at its Mt Isa North project, revealing new copper mineralisation zones and multiple high-priority uranium targets. The discoveries set the stage for further drilling and resource definition.
Maxwell Dee
Maxwell Dee
24 July 2025